In addition, pharmacological inhibition of the CXCL12/CXCR4 axis with WZ811 significantly attenuated lung fibrosis after BLM challenge reflected by morphological changes, ɑ-SMA, Col III, and TGF-β1 levels, and HYP content. Here, CXCL12 is linked to pulmonary fibrosis.